Search research articles
Contact Us
Filters
Showing results (31-40 of 134) with videos related to
Page
of 14
Sort By:
Critical Reviews in Oncology/Hematology
|
May 9, 2022
The efficacy of immune checkpoint inhibitors in rare tumors: A systematic review of published clinical trials
Deniz Can Guven, Bettzy Stephen, Taha Koray Sahin, et al.
Cancers
|
May 14, 2025
Treatment-Related Adverse Events in Extended Stage Small Cell Lung Cancer Patients Receiving First-Line Chemoimmunotherapy Versus Chemotherapy Alone: A Systematic Review and Meta-Analysis
Elsa Vitale, Alessandro Rizzo, Lorenza Maistrello, et al.
Pharmaceuticals (Basel, Switzerland)
|
July 27, 2024
Prognostic Significance of Pan-Immune-Inflammation Value in Patients with HER2-Positive Metastatic Breast Cancer Treated with Trastuzumab Emtansine
Taha Koray Sahin, Arif Akyildiz, Osman Talha Dogan, et al.
Expert Review of Anticancer Therapy
|
December 29, 2025
Elacestrant in metastatic breast cancer: current advancements and future perspectives
Taha Koray Sahin, Binura Makasheva, Deniz Can Guven, et al.
Heliyon
|
April 1, 2024
Datopotamab deruxtecan: A novel antibody drug conjugate for triple-negative breast cancer
Francesca Matilde Schipilliti, Denise Drittone, Federica Mazzuca, et al.
Critical Reviews in Oncology/Hematology
|
November 20, 2021
A systematic review and meta-analysis of the association between circulating tumor DNA (ctDNA) and prognosis in pancreatic cancer
Deniz Can Guven, Taha Koray Sahin, Hasan Cagri Yildirim, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
October 11, 2023
Immune checkpoint inhibitor-related hearing loss: a systematic review and analysis of individual patient data
Deniz Can Guven, Enes Erul, Yunus Kaygusuz, et al.
Frontiers in Oncology
|
October 5, 2020
Perspectives, Knowledge, and Fears of Cancer Patients About COVID-19
Deniz Can Guven, Taha Koray Sahin, Oktay Halit Aktepe, et al.
Expert Review of Anticancer Therapy
|
May 24, 2023
Optimal adjuvant treatment strategies for TNBC patients with residual disease after neoadjuvant treatment
Deniz Can Guven, Hasan Cagri Yildirim, Fatih Kus, et al.
Anti-Cancer Drugs
|
February 2, 2023
A chance in hopeless cancer: 5-year complete remission after oxaliplatin-based therapy in a patient with BRCA2 mutant metastatic pancreatic cancer
Hasan Cagri Yildirim, Rashad Ismayilov, Arif Akyildiz, et al.
Page
of 14
Search research articles
Search
Showing results (31-40 of 134) with videos related to
Sort By:
Page
of 14
Critical Reviews in Oncology/Hematology
|
May 9, 2022
The efficacy of immune checkpoint inhibitors in rare tumors: A systematic review of published clinical trials
Deniz Can Guven, Bettzy Stephen, Taha Koray Sahin, et al.
Cancers
|
May 14, 2025
Treatment-Related Adverse Events in Extended Stage Small Cell Lung Cancer Patients Receiving First-Line Chemoimmunotherapy Versus Chemotherapy Alone: A Systematic Review and Meta-Analysis
Elsa Vitale, Alessandro Rizzo, Lorenza Maistrello, et al.
Pharmaceuticals (Basel, Switzerland)
|
July 27, 2024
Prognostic Significance of Pan-Immune-Inflammation Value in Patients with HER2-Positive Metastatic Breast Cancer Treated with Trastuzumab Emtansine
Taha Koray Sahin, Arif Akyildiz, Osman Talha Dogan, et al.
Expert Review of Anticancer Therapy
|
December 29, 2025
Elacestrant in metastatic breast cancer: current advancements and future perspectives
Taha Koray Sahin, Binura Makasheva, Deniz Can Guven, et al.
Heliyon
|
April 1, 2024
Datopotamab deruxtecan: A novel antibody drug conjugate for triple-negative breast cancer
Francesca Matilde Schipilliti, Denise Drittone, Federica Mazzuca, et al.
Critical Reviews in Oncology/Hematology
|
November 20, 2021
A systematic review and meta-analysis of the association between circulating tumor DNA (ctDNA) and prognosis in pancreatic cancer
Deniz Can Guven, Taha Koray Sahin, Hasan Cagri Yildirim, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
October 11, 2023
Immune checkpoint inhibitor-related hearing loss: a systematic review and analysis of individual patient data
Deniz Can Guven, Enes Erul, Yunus Kaygusuz, et al.
Frontiers in Oncology
|
October 5, 2020
Perspectives, Knowledge, and Fears of Cancer Patients About COVID-19
Deniz Can Guven, Taha Koray Sahin, Oktay Halit Aktepe, et al.
Expert Review of Anticancer Therapy
|
May 24, 2023
Optimal adjuvant treatment strategies for TNBC patients with residual disease after neoadjuvant treatment
Deniz Can Guven, Hasan Cagri Yildirim, Fatih Kus, et al.
Anti-Cancer Drugs
|
February 2, 2023
A chance in hopeless cancer: 5-year complete remission after oxaliplatin-based therapy in a patient with BRCA2 mutant metastatic pancreatic cancer
Hasan Cagri Yildirim, Rashad Ismayilov, Arif Akyildiz, et al.
Page
of 14